172 related articles for article (PubMed ID: 9220694)
1. Cost containment for treating hypertension in African Americans: impact of a combined ACE inhibitor-calcium channel blocker.
Kountz DS
J Natl Med Assoc; 1997 Jul; 89(7):457-60. PubMed ID: 9220694
[TBL] [Abstract][Full Text] [Related]
2. Results of a pilot pharmacotherapy quality improvement program using fixed-dose, combination amlodipine/benazepril antihypertensive therapy in a long-term care setting.
Sapienza S; Sacco P; Floyd K; DiCesare J; Doan QD
Clin Ther; 2003 Jun; 25(6):1872-87. PubMed ID: 12860503
[TBL] [Abstract][Full Text] [Related]
3. Compliance with antihypertensive therapy in the elderly: a comparison of fixed-dose combination amlodipine/benazepril versus component-based free-combination therapy.
Dickson M; Plauschinat CA
Am J Cardiovasc Drugs; 2008; 8(1):45-50. PubMed ID: 18303937
[TBL] [Abstract][Full Text] [Related]
4. Adherence to antihypertensive therapy with fixed-dose amlodipine besylate/benazepril HCl versus comparable component-based therapy.
Taylor AA; Shoheiber O
Congest Heart Fail; 2003; 9(6):324-32. PubMed ID: 14688505
[TBL] [Abstract][Full Text] [Related]
5. Blood pressure effects of high-dose amlodipine-benazepril combination in Black and White hypertensive patients not controlled on monotherapy.
Chrysant SG
Drugs R D; 2012 Jun; 12(2):57-64. PubMed ID: 22571394
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertension.
Hilleman DE; Reyes AP; Wurdeman RL; Faulkner M
J Hum Hypertens; 2001 Aug; 15(8):559-65. PubMed ID: 11494095
[TBL] [Abstract][Full Text] [Related]
7. Patterns of antihypertensive use among patients in the US Department of Defense database initially prescribed an angiotensin-converting enzyme inhibitor or calcium channel blocker.
Okano GJ; Rascati KL; Wilson JP; Remund DD; Grabenstein JD; Brixner DI
Clin Ther; 1997; 19(6):1433-45; discussion 1424-5. PubMed ID: 9444451
[TBL] [Abstract][Full Text] [Related]
8. Effect of fixed-dose ACE-inhibitor/calcium channel blocker combination therapy vs. ACE-inhibitor monotherapy on arterial compliance in hypertensive patients with type 2 diabetes.
Winer N; Folker A; Murphy JA; Hung E; Bard M; Perkelvald A; Sowers JR; Bakris GL
Prev Cardiol; 2005; 8(2):87-92. PubMed ID: 15860983
[TBL] [Abstract][Full Text] [Related]
9. Comparison of antihypertensive effects of an angiotensin-converting enzyme inhibitor, a calcium antagonist and a diuretic in patients with hypertension not controlled by angiotensin receptor blocker monotherapy.
Stergiou GS; Makris T; Papavasiliou M; Efstathiou S; Manolis A
J Hypertens; 2005 Apr; 23(4):883-9. PubMed ID: 15775795
[TBL] [Abstract][Full Text] [Related]
10. Adherence patterns among patients treated with fixed-dose combination versus separate antihypertensive agents.
Gerbino PP; Shoheiber O
Am J Health Syst Pharm; 2007 Jun; 64(12):1279-83. PubMed ID: 17563050
[TBL] [Abstract][Full Text] [Related]
11. [One-year persistence of fixed-dose combinations of angiotensin-converting enzyme inhibitor and calcium channel blocker in hypertensive patients].
Simonyi G; Ferenci T; Finta E; Igaz I; Balogh S; Gasparics R; Medvegy M
Orv Hetil; 2019 Mar; 160(9):343-348. PubMed ID: 30798621
[TBL] [Abstract][Full Text] [Related]
12. Amlodipine/benazepril combination therapy for hypertensive patients nonresponsive to benazepril monotherapy.
Chrysant SG; Bakris GL
Am J Hypertens; 2004 Jul; 17(7):590-6. PubMed ID: 15233978
[TBL] [Abstract][Full Text] [Related]
13. Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy.
Baser O; Andrews LM; Wang L; Xie L
J Med Econ; 2011; 14(5):576-83. PubMed ID: 21728914
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertension.
Caro JJ; Lee K
Curr Hypertens Rep; 2002 Dec; 4(6):417-8. PubMed ID: 12419166
[No Abstract] [Full Text] [Related]
15. Racial differences in medication compliance and healthcare utilization among hypertensive Medicaid recipients: fixed-dose vs free-combination treatment.
Dickson M; Plauschinat CA
Ethn Dis; 2008; 18(2):204-9. PubMed ID: 18507275
[TBL] [Abstract][Full Text] [Related]
16. Combined therapy with benazepril and amlodipine in the treatment of hypertension inadequately controlled by an ACE inhibitor alone.
Fogari R; Corea L; Cardoni O; Cosmi F; Porcellati C; Innocenti P; Provvidenza M; Timio M; Bentivoglio M; Bertocchi F; Zoppi A
J Cardiovasc Pharmacol; 1997 Oct; 30(4):497-503. PubMed ID: 9335410
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of benazepril monotherapy to amlodipine plus benazepril in the treatment of patients with mild and moderate hypertension: a multicentre, randomized, double-blind, parallel-controlled study].
Fan CM; Yan LR; Tao YK; Wang L; Li YQ; Gao MM; Wang YN; Li CX; Wang XW; Lu XL; Pang HM; Li YS
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jan; 39(1):57-60. PubMed ID: 21418799
[TBL] [Abstract][Full Text] [Related]
18. Effect of antihypertensive monotherapy and combination therapy on arterial distensibility and left ventricular mass.
Neutel JM; Smith DH; Weber MA
Am J Hypertens; 2004 Jan; 17(1):37-42. PubMed ID: 14700510
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the efficacy and safety profiles of two fixed-dose combinations of antihypertensive agents, amlodipine/benazepril versus valsartan/hydrochlorothiazide, in patients with type 2 diabetes mellitus and hypertension: a 16-week, multicenter, randomized, double-blind, noninferiority study.
Lee IT; Hung YJ; Chen JF; Wang CY; Lee WJ; Sheu WH
Clin Ther; 2012 Aug; 34(8):1735-50. PubMed ID: 22784975
[TBL] [Abstract][Full Text] [Related]
20. Comparison of efficacy and side effects of combination therapy of angiotensin-converting enzyme inhibitor (benazepril) with calcium antagonist (either nifedipine or amlodipine) versus high-dose calcium antagonist monotherapy for systemic hypertension.
Messerli FH; Oparil S; Feng Z
Am J Cardiol; 2000 Dec; 86(11):1182-7. PubMed ID: 11090788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
